CClinicalTrials.gg
CompletedNCT03426813Updated Feb 8, 2018

Early Mobilization of Patients With Community-acquired Pneumonia

An interventional study of Historical control group for early mobilization in Pneumonia, sponsored by Regionshospital Nordjylland. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-02-08.

Sponsored by Regionshospital Nordjylland · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Pneumonia is a common health problem.This thesis may clarify whether early mobilization influence the time these patients are hospitalized, whether they are rehospitalized and whether it is possible to reduce the mortality rate.

Read the detailed description

Pneumonia is a common health problem. More than 100,000 Danes contract pneumonia every year, and around 15,000 of these are hospitalized. The main treatment is antibiotics. An American study indicates that patients who are mobilized early are hospitalized for a shorter period of time. The objective of the thesis is: to determine the effect of mobilization within 24 hours after hospitalization of patients with pneumonia. The result will be number of hospitalization days, rehospitalisation and mortality.

Patients with pneumonia hospitalized in the period 1 September 2012 - 28 February 2013 in the Medical Centre, lung unit 204B at Vendsyssel Hospital will be included in the project. Within the first 24 hours of hospitalization, they will be tested by a physiotherapist and mobilized.

There are significant costs associated with the treatment of patients with pneumonia - both economic costs and human costs. This thesis may clarify whether early mobilization influence the time these patients are hospitalized, whether they are rehospitalized and whether it is possible to reduce the mortality rate.

02

Conditions studied

  • Pneumonia

Browse trials for

Keywords

  • mobilization
  • physiotherapy
  • community-acquired pneumonia
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients with community-acquired pneumonia

Exclusion criteria

Exclusion Criteria:

  • dementia
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
98 participants (actual)

Study arms

  • Other
    Early mobilization

    Historical control group for early mobilization

    Other: Historical control group for early mobilization

Interventions

  • OtherHistorical control group for early mobilization
05

What researchers measure

Primary outcomes

  1. The number of hospitalization days

    Length of stay

    Time frame: 6 months

Secondary outcomes

  1. Number of rehospitalizations

    Rehospitalizations

    Time frame: 6 months after 1st hospitalization

Other outcomes

  1. Mortality

    Mortality

    Time frame: 6 months after 1st hospitalization

06

Study locations

1 site
  • North Denmark Hospital
    Hjørring, 9800, Denmark
07

Registry details

Key details

Study ID
NCT03426813
Lead sponsor
Regionshospital Nordjylland
Collaborators
Hvidovre University Hospital
Responsible party
Dorte Melgaard Kristiansen (Development therapist, Regionshospital Nordjylland) — Principal investigator
First posted
Feb 8, 2018
Start date
Oct 2012
Primary completion
Oct 2013
Completion
Dec 2013
Last update
Feb 8, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion